The ontogeny of apomorphine-induced alterations of neostriatal dopamine release: Effects on potassium-evoked release

The effects of apomorphine (0.05, 0.1, and 1.0 mg/kg, s.c.) on K⁺-evoked dopamine release were studied through the use of in vivo microdialysis in the neostriatum of developing and adult rats. Fifteen-minute samples were collected from urethane-anesthetized rats 5, 10–11, 21–22, 35–36 days of age, and adults, and quantified by high performance liquid chromatography with electrochemical detection. Apomorphine attenuated K⁺-evoked dopamine release in all age groups, suggesting that the dopamine autoreceptor modulating release in the neostriatum is functional by 5 days of age. A dose-response effect of apomorphine was observed in all age groups except at 5 and 10 days of age. Absolute levels of extracellular dopamine were significantly lower at 5 and 10 days of age compared with the other ages, and the effectiveness of a high-K⁺ artificial cerebrospinal fluid to evoke dopamine release increased with age.